Metabolite

KNApSAcK Entry

id C00002641
Name Cannabidiol
CAS RN 13956-29-1
Standard InChI InChI=1S/C21H30O2/c1-5-6-7-8-16-12-19(22)21(20(23)13-16)18-11-15(4)9-10-17(18)14(2)3/h11-13,17-18,22-23H,2,5-10H2,1,3-4H3/t17-,18+/m0/s1
Standard InChI (Main Layer) InChI=1S/C21H30O2/c1-5-6-7-8-16-12-19(22)21(20(23)13-16)18-11-15(4)9-10-17(18)14(2)3/h11-13,17-18,22-23H,2,5-10H2,1,3-4H3

Cluster

Phytochemical cluster No. 66
KCF-S cluster No. 5008

Link

ChEMBL

By standard InChI CHEMBL190461
By standard InChI Main Layer CHEMBL76762 CHEMBL190461 CHEMBL236171

KEGG

By LinkDB C07578

CTD

By CAS RN D002185

Species

Summary

Plant class

class name count
rosids 1

Family

family name count
Cannabaceae 1

List (1)

* NCBI
KNApSAcK organism *ID *family *plant class *kingdom
Cannabis sativa var. indica 3482 Cannabaceae rosids Viridiplantae

Human Protein / Gene in interaction

3 ChEMBL Protein in interactions

accession description class description compound assay ID (# of activities) # of diseases
(OMIM / KEGG)
P34972 Cannabinoid receptor 2 Cannabinoid receptor CHEMBL76762 CHEMBL190461 CHEMBL236171 CHEMBL658964 (1) CHEMBL768189 (1)
CHEMBL925156 (2) CHEMBL1117767 (1)
0 / 0
Q9Y2T6 G-protein coupled receptor 55 Lysophosphatidylinositol receptor CHEMBL190461 CHEMBL1117885 (1)
0 / 0
P21554 Cannabinoid receptor 1 Cannabinoid receptor CHEMBL76762 CHEMBL190461 CHEMBL236171 CHEMBL858761 (1) CHEMBL768189 (1)
CHEMBL901108 (1) CHEMBL925155 (2)
CHEMBL1117766 (1)
0 / 0

CTD interaction (35)

compound gene gene name gene description interaction interaction type form reference
pmid
D002185 1268 CNR1
CANN6
CB-R
CB1
CB1A
CB1K5
CB1R
CNR
cannabinoid receptor 1 (brain) CNR1 protein promotes the reaction [Cannabidiol results in decreased secretion of SERPINE1 protein] decreases secretion
/ increases reaction
protein 20668920
D002185 1269 CNR2
CB-2
CB2
CX5
cannabinoid receptor 2 (macrophage) CNR2 protein promotes the reaction [Cannabidiol results in decreased secretion of SERPINE1 protein] decreases secretion
/ increases reaction
protein 20668920
D002185 3383 ICAM1
BB2
CD54
P3.58
intercellular adhesion molecule 1 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Cannabidiol results in increased expression of ICAM1 mRNA] decreases reaction
/ increases expression
mRNA 22198381
D002185 3383 ICAM1
BB2
CD54
P3.58
intercellular adhesion molecule 1 AM 251 inhibits the reaction [Cannabidiol results in increased expression of ICAM1 mRNA] decreases reaction
/ increases expression
mRNA 22198381
D002185 3383 ICAM1
BB2
CD54
P3.58
intercellular adhesion molecule 1 Cannabidiol results in increased expression of ICAM1 mRNA increases expression
mRNA 22198381
D002185 3383 ICAM1
BB2
CD54
P3.58
intercellular adhesion molecule 1 Cannabidiol results in increased expression of ICAM1 protein increases expression
protein 22198381
D002185 3383 ICAM1
BB2
CD54
P3.58
intercellular adhesion molecule 1 capsazepine inhibits the reaction [Cannabidiol results in increased expression of ICAM1 mRNA] decreases reaction
/ increases expression
mRNA 22198381
D002185 3383 ICAM1
BB2
CD54
P3.58
intercellular adhesion molecule 1 ICAM1 mutant form inhibits the reaction [Cannabidiol results in increased expression of TIMP1 protein] decreases reaction
/ increases expression
mutant form 22198381
D002185 3383 ICAM1
BB2
CD54
P3.58
intercellular adhesion molecule 1 iodopravadoline inhibits the reaction [Cannabidiol results in increased expression of ICAM1 mRNA] decreases reaction
/ increases expression
mRNA 22198381
D002185 3620 IDO1
IDO
IDO-1
INDO
indoleamine 2,3-dioxygenase 1 (EC:1.13.11.52) AM 281 promotes the reaction [Cannabidiol inhibits the reaction [Plant Preparations results in increased activity of IDO1 protein]] decreases reaction
/ increases activity
/ increases reaction
protein 19167098
D002185 3620 IDO1
IDO
IDO-1
INDO
indoleamine 2,3-dioxygenase 1 (EC:1.13.11.52) Cannabidiol inhibits the reaction [Plant Preparations results in increased activity of IDO1 protein] decreases reaction
/ increases activity
protein 19167098
D002185 3620 IDO1
IDO
IDO-1
INDO
indoleamine 2,3-dioxygenase 1 (EC:1.13.11.52) Cannabidiol inhibits the reaction [[Plant Preparations results in increased activity of IDO1 protein] which results in increased abundance of Neopterin] decreases reaction
/ increases abundance
/ increases activity
protein 19167098
D002185 3620 IDO1
IDO
IDO-1
INDO
indoleamine 2,3-dioxygenase 1 (EC:1.13.11.52) Cannabidiol inhibits the reaction [Plant Preparations results in increased expression of IDO1 mRNA] decreases reaction
/ increases expression
mRNA 19167098
D002185 3620 IDO1
IDO
IDO-1
INDO
indoleamine 2,3-dioxygenase 1 (EC:1.13.11.52) iodopravadoline promotes the reaction [Cannabidiol inhibits the reaction [Plant Preparations results in increased activity of IDO1 protein]] decreases reaction
/ increases activity
/ increases reaction
protein 19167098
D002185 3458 IFNG
IFG
IFI
interferon, gamma Cannabidiol affects the reaction [Plant Preparations results in increased secretion of IFNG protein] affects reaction
/ increases secretion
protein 19167098
D002185 3458 IFNG
IFG
IFI
interferon, gamma Cannabidiol inhibits the reaction [Plant Preparations results in increased expression of IFNG mRNA] decreases reaction
/ increases expression
mRNA 19167098
D002185 5054 SERPINE1
PAI
PAI-1
PAI1
PLANH1
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 Cannabidiol results in decreased expression of SERPINE1 mRNA decreases expression
mRNA 20668920
D002185 5054 SERPINE1
PAI
PAI-1
PAI1
PLANH1
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 Cannabidiol results in decreased secretion of SERPINE1 protein decreases secretion
protein 20668920
D002185 5054 SERPINE1
PAI
PAI-1
PAI1
PLANH1
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 CNR1 protein promotes the reaction [Cannabidiol results in decreased secretion of SERPINE1 protein] decreases secretion
/ increases reaction
protein 20668920
D002185 5054 SERPINE1
PAI
PAI-1
PAI1
PLANH1
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 CNR2 protein promotes the reaction [Cannabidiol results in decreased secretion of SERPINE1 protein] decreases secretion
/ increases reaction
protein 20668920
D002185 5054 SERPINE1
PAI
PAI-1
PAI1
PLANH1
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 SERPINE1 protein results in increased susceptibility to Cannabidiol increases response to substance
protein 20668920
D002185 5054 SERPINE1
PAI
PAI-1
PAI1
PLANH1
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 TRPV1 protein promotes the reaction [Cannabidiol results in decreased secretion of SERPINE1 protein] decreases secretion
/ increases reaction
protein 20668920
D002185 7076 TIMP1
CLGI
EPA
EPO
HCI
TIMP
TIMP metallopeptidase inhibitor 1 Cannabidiol results in increased expression of TIMP1 mRNA increases expression
mRNA 22198381
D002185 7076 TIMP1
CLGI
EPA
EPO
HCI
TIMP
TIMP metallopeptidase inhibitor 1 Cannabidiol results in increased expression of TIMP1 protein increases expression
protein 22198381
D002185 7076 TIMP1
CLGI
EPA
EPO
HCI
TIMP
TIMP metallopeptidase inhibitor 1 ICAM1 mutant form inhibits the reaction [Cannabidiol results in increased expression of TIMP1 protein] decreases reaction
/ increases expression
protein 22198381
D002185 7442 TRPV1
VR1
transient receptor potential cation channel, subfamily V, member 1 Cannabidiol inhibits the reaction [Capsaicin binds to TRPV1 protein] affects binding
/ decreases reaction
protein 11606325
D002185 7442 TRPV1
VR1
transient receptor potential cation channel, subfamily V, member 1 Cannabidiol inhibits the reaction [[Capsaicin binds to TRPV1 protein] which results in increased uptake of Calcium] affects binding
/ decreases reaction
/ increases uptake
protein 11606325
D002185 7442 TRPV1
VR1
transient receptor potential cation channel, subfamily V, member 1 Cannabidiol inhibits the reaction [resiniferatoxin binds to TRPV1 protein] affects binding
/ decreases reaction
protein 11606325
D002185 7442 TRPV1
VR1
transient receptor potential cation channel, subfamily V, member 1 Cannabidiol inhibits the reaction [[resiniferatoxin binds to TRPV1 protein] which results in increased uptake of Calcium] affects binding
/ decreases reaction
/ increases uptake
protein 11606325
D002185 7442 TRPV1
VR1
transient receptor potential cation channel, subfamily V, member 1 Cannabidiol results in increased activity of TRPV1 protein increases activity
protein 11606325
D002185 7442 TRPV1
VR1
transient receptor potential cation channel, subfamily V, member 1 [Cannabidiol results in increased activity of TRPV1 protein] which results in increased uptake of Calcium increases activity
/ increases uptake
protein 11606325
D002185 7442 TRPV1
VR1
transient receptor potential cation channel, subfamily V, member 1 capsazepine inhibits the reaction [Cannabidiol results in increased activity of TRPV1 protein] decreases reaction
/ increases activity
protein 11606325
D002185 7442 TRPV1
VR1
transient receptor potential cation channel, subfamily V, member 1 capsazepine inhibits the reaction [[Cannabidiol results in increased activity of TRPV1 protein] which results in increased uptake of Calcium] decreases reaction
/ increases activity
/ increases uptake
protein 11606325
D002185 7442 TRPV1
VR1
transient receptor potential cation channel, subfamily V, member 1 TRPV1 protein promotes the reaction [Cannabidiol results in decreased secretion of SERPINE1 protein] decreases secretion
/ increases reaction
protein 20668920
D002185 51393 TRPV2
VRL
VRL-1
VRL1
transient receptor potential cation channel, subfamily V, member 2 Cannabidiol results in increased activity of TRPV2 protein increases activity
protein 18550765

Related Disease

Diseases related to CTD interactions

12 disease from interactions of metabolites

MeSH disease OMIM compound disease name evidence type reference
pmid
D001714 D002185 Bipolar Disorder therapeutic
19939866
D003072 D002185 Cognition Disorders therapeutic
21350020
D004421 D002185 Dystonia therapeutic
3793381
D007022 D002185 Hypotension marker/mechanism
3793381
10570211
D008569 D002185 Memory Disorders marker/mechanism
16406104
D009325 D002185 Nausea therapeutic
21827451
D009362 D002185 Neoplasm Metastasis therapeutic
22198381
D011605 D002185 Psychoses, Substance-Induced therapeutic
16612464
D012559 D002185 Schizophrenia therapeutic
16612464
D012640 D002185 Seizures marker/mechanism
therapeutic
841172
10605059
D014839 D002185 Vomiting therapeutic
21827451
D014987 D002185 Xerostomia marker/mechanism
3793381